肝硬化急性失代偿患者门静脉血栓的患病率与临床意义
该回顾性研究基于中国慢加急性肝衰竭联盟两个队列共2826例肝硬化患者,分析门静脉血栓(PVT)在急性失代偿(AD)患者中的患病率及临床意义。
要点
- 肝硬化急性失代偿患者PVT患病率9.36%,高于无AD患者的5.24%。
- 脾切除和内镜下硬化治疗是PVT独立危险因素。
核心结论
- 肝硬化急性失代偿患者PVT患病率显著高于无AD患者,PVT与静脉曲张出血增加相关,可能增加AD风险。
主要发现
- 急性失代偿合并PVT患者中63.37%为新近发生PVT。
- 合并PVT与不合并PVT的肝硬化急性失代偿患者1年死亡率无显著差异。
关键数值与推荐
- 脾切除和内镜下硬化治疗是肝硬化急性失代偿患者PVT的独立危险因素。
临床怎么用
- 对肝硬化急性失代偿患者应定期筛查PVT以降低门静脉高压风险,尤其关注有脾切除或内镜下硬化治疗史者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Portal vein thrombosis (PVT) is a common and serious complication in patients with cirrhosis. However, little is known about PVT in patients with cirrhosis and acute decompensation (AD). We investigated the prevalence and clinical significance of PVT in nonmalignant patients with cirrhosis and AD. METHODS: We performed a retrospective study of 2 cohorts of patients with acute exacerbation of chronic liver disease who participated in the Chinese AcuTe on CHronic LIver FailurE study, established by the Chinese Chronic Liver Failure Consortium, from January 2015 through December 2016 (n = 2600 patients) and July 2018 through January 2019 (n = 1370 patients). We analyzed data on the prevalence, clinical manifestations, and risk factors of PVT from 2826 patients with cirrhosis, with and without AD. RESULTS: The prevalence of PVT in patients with cirrhosis and AD was 9.36%, which was significantly higher than in patients with cirrhosis without AD (5.24%) (P = .04). Among patients with cirrhosis and AD, 63.37% developed PVT recently (the first detected PVT with no indication of chronic PVT). Compared with patients without PVT, a significantly higher proportion of patients with PVT had variceal bleeding (47.33% vs 19.63%; P < .001) and patients with PVT had a significantly higher median serum level of D-dimer (2.07 vs 1.25; P < .001). Splenectomy and endoscopic sclerotherapy were independent risk factors for PVT in patients with cirrhosis and AD. The 1-year mortality rate did not differ significantly between patients with vs without PVT. CONCLUSIONS: In an analysis of data from 2826 patients with cirrhosis, a significantly higher proportion of those with AD had PVT than those without AD. PVT was associated with increased variceal bleeding, which would increase the risk for AD. Strategies are needed to prevent PVT in patients with cirrhosis, through regular screening, to reduce portal hypertension. ClinicalTrials.gov no: NCT02457637 and NCT03641872.
引用
- Zhang Y, Xu BY, Wang XB, et al. Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute Decompensation. Clin Gastroenterol Hepatol. 2020. PMID: 32109631. doi:10.1016/j.cgh.2020.02.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。